GM-CSF-independent development of dendritic cells from bone marrow cells in the GM-CSF-receptor-deficient mouse

Transplant Proc. 2000 Nov;32(7):2458-9. doi: 10.1016/s0041-1345(00)01742-5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow Cells / cytology*
  • Bone Marrow Cells / drug effects
  • Bone Marrow Cells / immunology
  • Culture Media, Conditioned
  • Dendritic Cells / cytology*
  • Dendritic Cells / drug effects
  • Dendritic Cells / immunology
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology*
  • Humans
  • Immunophenotyping
  • Interleukin-6 / pharmacology
  • Lymphocyte Activation
  • Lymphocytes / immunology*
  • Mice
  • Mice, Knockout
  • Proto-Oncogene Proteins / physiology
  • Rats
  • Rats, Inbred Lew
  • Receptor Protein-Tyrosine Kinases / physiology
  • Receptors, Granulocyte-Macrophage Colony-Stimulating Factor / deficiency
  • Receptors, Granulocyte-Macrophage Colony-Stimulating Factor / genetics
  • Receptors, Granulocyte-Macrophage Colony-Stimulating Factor / physiology*
  • Recombinant Proteins / pharmacology
  • Spleen / immunology
  • Tumor Necrosis Factor-alpha / pharmacology
  • fms-Like Tyrosine Kinase 3

Substances

  • Culture Media, Conditioned
  • Interleukin-6
  • Proto-Oncogene Proteins
  • Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • FLT3 protein, human
  • Flt3 protein, mouse
  • Receptor Protein-Tyrosine Kinases
  • fms-Like Tyrosine Kinase 3